Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).
Bousmah MA, Protopopescu C, Mpoudi-Etame M, Omgba Bassega P, Maradan G, Olinga J, Varloteaux M, Tovar-Sanchez T, Delaporte É, Kouanfack C, Boyer S; NAMSAL ANRS 12313 Study Group. Bousmah MA, et al. Among authors: maradan g. J Acquir Immune Defic Syndr. 2023 Nov 1;94(3):262-272. doi: 10.1097/QAI.0000000000003273. J Acquir Immune Defic Syndr. 2023. PMID: 37851566 Clinical Trial.
Treatment interruption in HIV-positive patients followed up in Cameroon's antiretroviral treatment programme: individual and health care supply-related factors (ANRS-12288 EVOLCam survey).
Tong C, Suzan-Monti M, Sagaon-Teyssier L, Mimi M, Laurent C, Maradan G, Mengue MT, Spire B, Kuaban C, Vidal L, Boyer S; EVOL Cam group. Tong C, et al. Among authors: maradan g. Trop Med Int Health. 2018 Mar;23(3):315-326. doi: 10.1111/tmi.13030. Epub 2018 Feb 2. Trop Med Int Health. 2018. PMID: 29327419 Free article.
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
Liégeois F, Boyer S, Eymard-Duvernay S, Carrieri P, Kouanfack C, Domyeum J, Maradan G, Ducos J, Mpoudi-Ngolé E, Spire B, Delaporte E, Kuaban C, Vidal L, Laurent C; EVOLCAM study group. Liégeois F, et al. Among authors: maradan g. BMC Infect Dis. 2020 Jan 15;20(1):49. doi: 10.1186/s12879-020-4784-7. BMC Infect Dis. 2020. PMID: 31941464 Free PMC article.
Reaching a Different Population of MSM in West Africa With the Integration of PrEP Into a Comprehensive Prevention Package (CohMSM-PrEP ANRS 12369-Expertise France).
Eubanks A, Dembélé Keita B, Anoma C, Dah TTE, Mensah E, Maradan G, Bourrelly M, Mora M, Riegel L, Rojas Castro D, Yaya I, Spire B, Laurent C, Sagaon-Teyssier L; CohMSM-PrEP Study Group. Eubanks A, et al. Among authors: maradan g. J Acquir Immune Defic Syndr. 2020 Nov 1;85(3):292-301. doi: 10.1097/QAI.0000000000002453. J Acquir Immune Defic Syndr. 2020. PMID: 32732768
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).
Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Bousmah MA, et al. Among authors: maradan g. Pharmacoeconomics. 2021 Mar;39(3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23. Pharmacoeconomics. 2021. PMID: 33355914 Free PMC article.
Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme.
Coulaud PJ, Protopopescu C, Ndiaye K, Baudoin M, Maradan G, Laurent C, Spire B, Vidal L, Kuaban C, Boyer S; EVOLCam Group. Coulaud PJ, et al. Among authors: maradan g. Health Policy Plan. 2021 Mar 26;36(2):137-148. doi: 10.1093/heapol/czaa153. Health Policy Plan. 2021. PMID: 33367696 Free article.
Hepatitis B Vaccination in Senegalese Children: Coverage, Timeliness, and Sociodemographic Determinants of Non-Adherence to Immunisation Schedules (ANRS 12356 AmBASS Survey).
Périères L, Marcellin F, Lo G, Protopopescu C, Ba EH, Coste M, Touré Kane C, Maradan G, Diallo A, Sokhna C, Boyer S, On Behalf Of The Anrs AmBASS Survey Study Group. Périères L, et al. Among authors: maradan g. Vaccines (Basel). 2021 May 15;9(5):510. doi: 10.3390/vaccines9050510. Vaccines (Basel). 2021. PMID: 34063390 Free PMC article.
79 results